Chuluyan H E, Schall T J, Yoshimura T, Issekutz A C
Department of Pediatrics, Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
J Leukoc Biol. 1995 Jul;58(1):71-9. doi: 10.1002/jlb.58.1.71.
We investigated the effect of interleukin-1 (IL-1) activation of human umbilical vein endothelium (HUVE) on human monocyte transendothelial migration induced by chemotactic factors. Monocyte migration across unactivated endothelium in response to macrophage inflammatory protein-1 alpha (MIP-1 alpha), RANTES, platelet-activating factor (PAF), or monocyte chemoattractant protein-1 (MCP-1) was completely inhibited (90%) by monoclonal antibodies (mAbs; 60.3) to CD18 of the CD11/CD18 complex on the monocyte and partially inhibited (by 75%) in response to C5a. When the HUVE was stimulated with IL-1 alpha (5 h, 0.1 ng/ml), monocyte migration in response to C5a, MIP-1 alpha, RANTES, or PAF was no longer inhibited by mAb to CD18. However, migration was blocked by the combination of mAb to the alpha 4-integrin (CD49d) chain of very late antigen-4 (CD49d/CD29) with the mAb to CD18. In contrast to the above stimuli, activation of the HUVE with IL-1 alpha inhibited the transendothelial migration of monocytes in response to MCP-1. mAbs to the adhesion molecules up-regulated on HUVE by IL-1, i.e., E-selectin (CD62E), intercellular adhesion molecule-1 (CD54) or vascular cell adhesion molecule-1 (CD106), did not reverse the inhibitory effect. Transendothelial migration in response to MCP-1 but not to C5a was inhibited by the treatment of monocytes with culture supernatant from IL-1 alpha-stimulated (but not from unstimulated) HUVE. Such supernatant contained chemotactic activity for monocytes, and a mAb to MCP-1 blocked the migration inhibitory effect of IL-1 activation of the HUVE monolayer, as well as the chemotactic activity in the supernatant from IL-1-stimulated HUVE. The inhibitory effect on migration of IL-1-stimulated HUVE was specific for monocytes because polymorphonuclear leukocyte transendothelial migration in response to IL-8 (a related chemokine) was not inhibited by IL-1 activation of HUVE.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了白细胞介素-1(IL-1)激活人脐静脉内皮细胞(HUVE)对趋化因子诱导的人单核细胞跨内皮迁移的影响。单核细胞在巨噬细胞炎性蛋白-1α(MIP-1α)、RANTES、血小板活化因子(PAF)或单核细胞趋化蛋白-1(MCP-1)作用下跨未激活内皮的迁移,被针对单核细胞上CD11/CD18复合物中CD18的单克隆抗体(mAbs;60.3)完全抑制(90%),而对C5a的反应则被部分抑制(75%)。当HUVE用IL-1α(5小时,0.1 ng/ml)刺激时,单核细胞对C5a、MIP-1α、RANTES或PAF的迁移不再被抗CD18的mAb抑制。然而,迁移被抗极迟抗原-4(CD49d/CD29)的α4整合素(CD49d)链的mAb与抗CD18的mAb联合阻断。与上述刺激相反,用IL-1α激活HUVE可抑制单核细胞对MCP-1的跨内皮迁移。针对IL-1上调的HUVE上的黏附分子,即E-选择素(CD62E)、细胞间黏附分子-1(CD54)或血管细胞黏附分子-1(CD106)的mAb,并未逆转这种抑制作用。用IL-1α刺激(而非未刺激)的HUVE的培养上清液处理单核细胞,可抑制对MCP-1而非C5a的跨内皮迁移。这种上清液含有对单核细胞的趋化活性,抗MCP-1的mAb可阻断IL-1激活的HUVE单层对迁移的抑制作用,以及IL-1刺激的HUVE上清液中的趋化活性。IL-1刺激的HUVE对迁移的抑制作用对单核细胞具有特异性,因为多形核白细胞对IL-8(一种相关趋化因子)的跨内皮迁移未被IL-1激活的HUVE抑制。(摘要截短于250字)